I agree that this site is using cookies. You can find further informations here.
X
Edwin DeJesus
167  results:
Search for persons X
?
1

P37: Switch from NNRTI plus FTC/TDF to E/C/F/TDF maintains ..:

Edwin, DeJesus ; Jason, Flamm ; Anton, Pozniak...
Journal of the International AIDS Society.  17 (2014)  2(Suppl 1) - p. , 2014
Link: https://doi.org/10.7448/..
 
?
2

P24: Long-term efficacy and safety of elvitegravir/cobicist..:

Nathan, Clumeck ; Jean-Michel, Molina ; Keith, Henry...
Journal of the International AIDS Society.  17 (2014)  2(Suppl 1) - p. , 2014
Link: https://doi.org/10.7448/..
 
?
3

Abacavir versus Zidovudine Combined with Lamivudine and Efa..:

Edwin DeJesus ; Gisela Herrera ; Eugenio Teofilo...
Clinical Infectious Diseases.  39 (2004)  7 - p. 1038-1046 , 2004
Link: https://www.jstor.org/st..
 
?
4

Once-Daily versus Twice-Daily Lamivudine, in Combination wi..:

Edwin DeJesus ; Debra McCarty ; Farthing, Charles F....
Clinical Infectious Diseases.  39 (2004)  3 - p. 411-418 , 2004
Link: https://www.jstor.org/st..
 
?
5

HIV rebound in HIV controllers is associated with a specifi..:

Cai, Yanhui ; Podlaha, Ondrej ; Deeks, Steven G....
European Journal of Immunology.  , 2024
Link: https://doi.org/10.1002/..
 
?
6

Safety of teropavimab and zinlirvimab with lenacapavir once..:

Eron, Joseph J ; Little, Susan J ; Crofoot, Gordon...
The Lancet HIV.  11 (2024)  3 - p. e146-e155 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and safety of the novel capsid inhibitor lenacapav..:

Ogbuagu, Onyema ; Segal-Maurer, Sorana ; Ratanasuwan, Winai...
The Lancet HIV.  10 (2023)  8 - p. e497-e505 , 2023
Link: https://doi.org/10.1016/..
 
?
8

1603. Efficacy, safety and tolerability of switching to dol..:

Rolle, Charlotte-Paige M ; Castano, Jamie ; Nguyen, Vu..
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
9

Treatment-related early discontinuations and adverse events..:

Rolle, Charlotte-Paige ; Castano, Jamie ; Nguyen, Vu...
Antiviral Therapy.  28 (2023)  2 - p. 135965352311637 , 2023
Link: https://doi.org/10.1177/..
 
?
10

Bictegravir/emtricitabine/tenofovir alafenamide as initial ..:

Sax, Paul E. ; Arribas, José R. ; Orkin, Chloe...
eClinicalMedicine.  59 (2023)  - p. 101991 , 2023
Link: https://doi.org/10.1016/..
 
?
11

1596. Efficacy and Safety of Long-Acting Subcutaneous Lenac..:

Ogbuagu, Onyema ; DeJesus, Edwin ; Berhe, Mezgebe...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
12

Week 96 Genotypic and Phenotypic Results of the Fostemsavir..:

Gartland, Margaret ; Cahn, Pedro ; DeJesus, Edwin...
Antimicrobial Agents and Chemotherapy.  66 (2022)  6 - p. , 2022
Link: https://doi.org/10.1128/..
 
?
13

Long-Term Efficacy, Safety, and Durability of Cabotegravir ..:

Sutton, Kenneth C ; De Vente, Jerome ; Leblanc, Roger...
Open Forum Infectious Diseases.  9 (2022)  4 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
14

Real-world efficacy and safety of switching to bictegravir/..:

Rolle, Charlotte-Paige ; Nguyen, Vu ; Patel, Kiran...
Medicine.  100 (2021)  38 - p. e27330 , 2021
Link: https://doi.org/10.1097/..
 
?
15

Virologic outcomes of switching to dolutegravir functional ..:

Rolle, Charlotte-Paige ; Nguyen, Vu ; Hinestrosa, Federico.
AIDS Research and Therapy.  18 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
1-15